1 year return (CAGR)
-41.33%
Alnylam Pharmaceuticals Inc Exchange (NASDAQ, USD)
ALNY
258.00
+1.61 (+0.61%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
10.51%
5 year return (CAGR)
5.47%
10 year return (CAGR)
14.39%
Computer Modeling Group 2027 Q1 - Turnarounds seldom turn?
Read MoreMarketcap
35.61B
Price/Sales
7.41
Ent value
38.10B
Price/Book
26.30
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
44.07
PEG
-
Forward P/E
21.14
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 258.58 |
| Daily high | 266.85 |
| Daily low | 258.02 |
| Daily Volume | 1.43M |
| All-time high | 491.22 |
| 1y analyst estimate | 370.20 |
| Beta | 0.28 |
| EPS (TTM) | 5.84 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALNY | S&P500 | |
| Current price drop from All-time high | -47.48% | -1.99% |
| Highest price drop | -83.58% | -56.47% |
| Date of highest drop | 3 Oct 2011 | 9 Mar 2009 |
| Avg drop from high | -30.75% | -10.69% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 1443 days | 1805 days |
News
